Anterior cingulate cortex gray matter abnormalities in adults with attention deficit hyperactivity disorder: A voxel-based morphometry study

Psychiatry Research - Neuroimaging

Volumn 191, Issue 1, 2011, Pages 31-35

  Amico, Francesco ^a   Stauber, Jonathan ^b   Koutsouleris, Nikolaos ^b   Frodl, Thomas ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

ACC; Adult ADHD; Anterior cingulate cortex; VBM; Voxel based morphometry

Indexed keywords

ADULT; AMYGDALOID NUCLEUS; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN DISEASE; BRAIN SIZE; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; LEFT HEMISPHERE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PRIORITY JOURNAL; RIGHT HEMISPHERE; VOLUMETRY; VOXEL BASED MORPHOMETRY; WHITE MATTER;

ADULT; ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; FEMALE; GYRUS CINGULI; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 78650172361     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2010.08.011     Document Type: Article

References (53)

1. Amico F., Meisenzahl E., Koutsouleris N., Reiser M., Möller H.J., Frodl T. Structural MRI correlates for vulnerability and resilience to major depressive disorder. Journal of Psychiatry & Neuroscience 2010, (Electronic publication ahead of print, 1 November). doi:10.1503/jpn.090186.
2. Aron A.R., Fletcher P.C., Bullmore E.T., Sahakian B.J., Robbins T.W.s, Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nature Neuroscience 2003, 6:115-116.
3. Ashburner J., Friston K.J. Unified segmentation. Neuroimage 2005, 26:839-851.
4. Barkley R.A. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychological Bulletin 1997, 121:65-94.
5. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961, 4:561-571.
6. Bernstein D.P., Fink L., Handelsman L., Foote J., Lovejoy M., Wenzel K., Sapareto E., Ruggiero J. Initial reliability and validity of a new retrospective measure of child abuse and neglect. The American Journal of Psychiatry 1994, 151:1132-1136.
7. Biederman J. Attention-deficit/hyperactivity disorder: a life-span perspective. The Journal of Clinical Psychiatry 1998, 59(Suppl 7):4-16.
8. Biederman J., Faraone S.V., Spencer T., Wilens T., Norman D., Lapey K.A., Mick E., Lehman B.K., Doyle A. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. The American Journal of Psychiatry 1993, 150:1792-1798.
9. Biederman J., Makris N., Valera E.M., Monuteaux M.C., Goldstein J.M., Buka S., Boriel D.L., Bandyopadhyay S., Kennedy D.N., Caviness V.S., Bush G., Aleardi M., Hammerness P., Faraone S.V., Seidman L.J. Towards further understanding of the co-morbidity between attention deficit hyperactivity disorder and bipolar disorder: a MRI study of brain volumes. Psychological Medicine 2008, 38:1045-1056.
10. Bookstein F.L. "Voxel-based morphometry" should not be used with imperfectly registered images. Neuroimage 2001, 14:1454-1462.
11. Brett M., Anton J.L., Valabregue R., Poline J.-B. Region of interest analysis using an SPM toolbox. Neuroimage 2002, 16.
12. Bush G., Frazier J.A., Rauch S.L., Seidman L.J., Whalen P.J., Jenike M.A., Rosen B.R., Biederman J. Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biological Psychiatry 1999, 45:1542-1552.
13. Carroll K.M., Rounsaville B.J. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Comprehensive Psychiatry 1993, 34:75-82.
14. Castellanos F.X., Giedd J.N., Marsh W.L., Hamburger S.D., Vaituzis A.C., Dickstein D.P., Sarfatti S.E., Vauss Y.C., Snell J.W., Lange N., Kaysen D., Krain A.L., Ritchie G.F., Rajapakse J.C., Rapoport J.L. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Archives of General Psychiatry 1996, 53:607-616.
15. Castellanos F.X., Lee P.P., Sharp W., Jeffries N.O., Greenstein D.K., Clasen L.S., Blumenthal J.D., James R.S., Ebens C.L., Walter J.M., Zijdenbos A., Evans A.C., Giedd J.N., Rapoport J.L. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA: Journal of the American Medical Association 2002, 288:1740-1748.
16. Conners C.K., Erhardt D., Sparrow E. Conner's Adult ADHD Rating Scales 1999, Multi-Healths System, Inc., North Tonawanda, NY.
17. Cuadra M.B., Cammoun L., Butz T., Cuisenaire O., Thiran J.P. Comparison and validation of tissue modelization and statistical classification methods in T1-weighted MR brain images. IEEE Transactions on Medical Imaging 2005, 24:1548-1565.
18. Drevets W.C. Neuroimaging studies of mood disorders. Biological Psychiatry 2000, 48:813-829.
19. Faraone S.V., Biederman J., Spencer T., Wilens T., Seidman L.J., Mick E., Doyle A.E. Attention-deficit/hyperactivity disorder in adults: an overview. Biological Psychiatry 2000, 48:9-20.
20. Filipek P.A., Semrud-Clikeman M., Steingard R.J., Renshaw P.F., Kennedy D.N., Biederman J. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 1997, 48:589-601.
21. Fukumoto M., Kubo H., Ogamo A.s Determination of nicotine content of popular cigarettes. Veterinary and Human Toxicology 1997, 39:225-227.
22. Garnock-Jones K.P., Keating G.M. Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents. Paediatric Drugs 2009, 11:203-226.
23. Gonzalez-Garrido A.A., Barrios F.A., de la Serna-Tuya J.M., Cocula-Leon H., Gomez-Velazquez F.R. Methylphenidate and short-term memory in young females with attention deficit hyperactivity disorder. A study using functional magnetic resonance imaging. Revista de Neurologia 2009, 48:509-514.
24. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001, 14:21-36.
25. Goodwin G.M. Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. Journal of Psychopharmacology 1997, 11:115-122.
26. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960, 23:56-62.
27. Hamilton M. Standardised assessment and recording of depressive symptoms. Psychiatria, Neurologia, Neurochirurgia 1969, 72:201-205.
28. Lancaster J.L., Rainey L.H., Summerlin J.L., Freitas C.S., Fox P.T., Evans A.C., Toga A.W., Mazziotta J.C. Automated labeling of the human brain: a preliminary report on the development and evaluation of a forward-transform method. Human Brain Mapping 1997, 5:238-242.
29. Lancaster J.L., Summerln J.L., Rainey L., Freitas C.S., Fox P.T. The Talairach Daemon, a database server for Talairach Atlas Labels. Neuroimage 1997, 5:S633.
30. Lancaster J.L., Woldorff M.G., Parsons L.M., Liotti M., Freitas C.S., Rainey L., Kochunov P.V., Nickerson D., Mikiten S.A., Fox P.T. Automated Talairach atlas labels for functional brain mapping. Human Brain Mapping 2000, 10:120-131.
31. Levy F. Dopamine vs noradrenaline: inverted-U effects and ADHD theories. The Australian and New Zealand Journal of Psychiatry 2009, 43:101-108.
32. MacQueen G.M. Magnetic resonance imaging and prediction of outcome in patients with major depressive disorder. Journal of Psychiatry & Neuroscience 2009, 34:343-349.
33. Mak A.K., Wong M.M., Han S.H., Lee T.M. Gray matter reduction associated with emotion regulation in female outpatients with major depressive disorder: a voxel-based morphometry study. Progress in Neuro-psychopharmacology & Biological Psychiatry 2009, 33:1184-1190.
34. Makris N., Seidman L.J., Valera E.M., Biederman J., Monuteaux M.C., Kennedy D.N., Caviness V.S., Bush G., Crum K., Brown A.B., Faraone S.V. Anterior cingulate volumetric alterations in treatment-naive adults with ADHD: a pilot study. Journal of Attention Disorders 2010, 13:407-413.
35. Maldjian J.A., Laurienti P.J., Kraft R.A., Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003, 19:1233-1239.
36. Maldjian J.A., Laurienti P.J., Burdette J.H. Precentral gyrus discrepancy in electronic versions of the Talairach atlas. Neuroimage 2004, 21:450-455.
37. Mattes J.A. The role of frontal lobe dysfunction in childhood hyperkinesis. Comprehensive Psychiatry 1980, 21:358-369.
38. Murphy K. Psychosocial treatments for ADHD in teens and adults: a practice-friendly review. Journal of Clinical Psychology 2005, 61:607-619.
39. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9:97-113.
40. Pennington B.F., Ozonoff S. Executive functions and developmental psychopathology. Journal of Child Psychology and Psychiatry 1996, 37:51-87.
41. Perlov E., Philipsen A., Tebartz van Elst L., Ebert D., Henning J., Maier S., Bubl E., Hesslinger B. Hippocampus and amygdala morphology in adults with attention-deficit hyperactivity disorder. Journal of Psychiatry & Neuroscience 2008, 33:509-515.
42. Safren S.A. Cognitive-behavioral approaches to ADHD treatment in adulthood. The Journal of Clinical Psychiatry 2006, 67(Suppl 8):46-50.
43. Seidman L.J., Doyle A., Fried R., Valera E., Crum K., Matthews L. Neuropsychological function in adults with attention-deficit/hyperactivity disorder. The Psychiatric Clinics of North America 2004, 27:261-282.
44. Seidman L.J., Valera E.M., Makris N. Structural brain imaging of attention-deficit/hyperactivity disorder. Biological Psychiatry 2005, 57:1263-1272.
45. Seidman L.J., Valera E.M., Makris N., Monuteaux M.C., Boriel D.L., Kelkar K., Kennedy D.N., Caviness V.S., Bush G., Aleardi M., Faraone S.V., Biederman J. Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging. Biological Psychiatry 2006, 60:1071-1080.
46. Shaywitz B.A., Klopper J.H., Gordon J.W. Methylphenidate in G-hydroxydopamine treated developing rat pups. Child Neurology 1978, 35:463-467.
47. Shihabuddin L., Buchsbaum M.S., Hazlett E.A., Haznedar M.M., Harvey P.D., Newman A., Schnur D.B., Spiegel-Cohen J., Wei T., Machac J., Knesaurek K., Vallabhajosula S., Biren M.A., Ciaravolo T.M., Luu-Hsia C. Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task. Archives of General Psychiatry 1998, 55:235-243.
48. Sowell E.R., Thompson P.M., Welcome S.E., Henkenius A.L., Toga A.W., Peterson B.S. Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet 2003, 362:1699-1707.
49. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15:273-289.
50. Valera E.M., Faraone S.V., Murray K.E., Seidman L.J. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biological Psychiatry 2007, 61:1361-1369.
51. Ward M.F., Wender P.H., Reimherr F.W. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. The American Journal of Psychiatry 1993, 150:885-890.
52. Whitwell J.L. Voxel-based morphometry: an automated technique for assessing structural changes in the brain. The Journal of Neuroscience 2009, 29:9661-9664.
53. Zametkin A.J., Nordahl T.E., Gross M., King A.C., Semple W.E., Rumsey J., Hamburger S., Cohen R.M. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. The New England Journal of Medicine 1990, 323:1361-1366.